相关实验视频

Updated: May 5, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

已知MTA合作型PRMT5抑制剂的综述

Mei Hu¹, Xiang Chen¹

¹Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University 1-1 Xiangling Road Luzhou Sichuan 646000 People's Republic of China 86487165@qq.com.

|December 18, 2024

概括

蛋白质氨酸甲基转移酶5 (PRMT5) 抑制剂作为癌症疗法具有前景,但毒性限制了它们的使用. 本审查审查了PRMT5抑制剂的设计,安全性和临床应用的潜在风险.

科学领域:

在瘤学瘤学.
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
药用化学医学化学

背景情况:

蛋白质氨酸甲基转移酶5 (PRMT5) 是一种关键的表观遗传调节剂,与各种癌症有关.
许多PRMT5抑制剂正在临床试验中,第二代药物显示合成致命潜力.
尽管有临床兴趣,但剂量限制性毒性阻止了PRMT5抑制剂的营销批准.

研究的目的:

审查甲基腺 (MTA) 合作型PRMT5抑制剂的设计策略和结构-活性关系 (SAR).
分析第一代和第二代PRMT5抑制剂的临床安全性.
讨论与PRMT5抑制剂开发相关的潜在的体内脆弱性和尼托拉胺风险.

主要方法:

在癌症治疗中对PRMT5抑制剂的文献综述.
对MTA合作抑制剂的结构-活性关系 (SAR) 的分析.
对代表性PRMT5抑制剂的临床安全数据的审查.

主要成果:

第二代PRMT5抑制剂基于合成致死性显示出显著的临床应用价值.
固有的剂量限制性毒性仍然是PRMT5抑制剂开发的挑战.
鉴定了芳香氨基部分的潜在in vivo脆弱性和尼托胺形成风险.

结论:

PRMT5是癌症治疗的有希望的合成致命标,类似于PARP抑制剂.
解决毒性和潜在的制造风险对于临床成功至关重要.
进一步研究PRMT5抑制剂的设计和安全性是治疗进步的必要条件.

更多相关视频

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Mitochondrial Precursor Proteins

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...